Interim results of a phase II multicenter study of the conditionally replicative oncolytic adenovirus DNX-2401 with pembrolizumab (Keytruda) for recurrent glioblastoma: Captive study (Keynote-192) Meeting Abstract
| Authors: | Zadeh, G.; Lang, F.; Daras, M.; Cloughesy, T.; Colman, H.; Ong, S.; Ramakrishna, R.; Vogelbaum, M.; Groves, M.; Nassiri, F.; Frederick, L. S.; Gammon, K.; Fulling, S.; Rowland, K. A.; Mitchell, E.; Ewald, B.; Tufaro, F.; Peterkin, J. |
| Abstract Title: | Interim results of a phase II multicenter study of the conditionally replicative oncolytic adenovirus DNX-2401 with pembrolizumab (Keytruda) for recurrent glioblastoma: Captive study (Keynote-192) |
| Meeting Title: | 23rd Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology |
| Journal Title: | Neuro-Oncology |
| Volume: | 20 |
| Issue: | Suppl. 6 |
| Meeting Dates: | 2018 Nov 15-18 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 1522-8517 |
| Publisher: | Oxford University Press |
| Date Published: | 2018-11-01 |
| Start Page: | vi6 |
| Language: | English |
| ACCESSION: | WOS:000460646300021 |
| PROVIDER: | wos |
| PMCID: | PMC6216117 |
| DOI: | 10.1093/neuonc/noy148 |
| Notes: | Meeting Abstract: ATIM-24 -- Source: Wos |
